CTLA-4-mediated posttranslational modifications direct cytotoxic T-lymphocyte differentiation
Sign Up to like & getrecommendations! Published in 2017 at "Cell Death and Differentiation"
DOI: 10.1038/cdd.2017.102
Abstract: The blockade of inhibitory receptors such as CTLA-4 (CD152) is being used as immune-checkpoint therapy, offering a powerful strategy to restore effective immune responses against tumors. To determine signal components that are induced under the… read more here.
Keywords: mediated posttranslational; ctla; ctla mediated; posttranslational modifications ... See more keywords